Skip to content

    Chemplast Sanmar

    CHEMPLASTS
    Chemicals·26 May 2026
    Management Summary

    Chemplast Sanmar faced a challenging FY26 marked by significant impairment and exceptional charges in its commodity PVC business due to market volatility and regulatory uncertainties. However, the Specialty Chemicals segment demonstrated strong growth, and the company commenced commercial production of R32 refrigerant gas. A committee has been formed to review strategic priorities and M&A opportunities to enhance long-term value.

    Highlights

    5
    • Q4 FY26 consolidated revenue grew 9% YoY to INR 1,256 crores.

    • Specialty Chemicals segment revenue increased 13% YoY to INR 475 crores, with volumes up 17% YoY.

    • Commercial production of R32 refrigerant gas commenced at the 2 kt swing plant.

    • Final findings from DGTR received for anti-dumping duty investigation against EU and Japan for Paste PVC.

    • Custom Manufactured Chemicals business shows early signs of recovery with a strong order book for FY27.

    Concerns

    5
    • FY26 was a challenging year with consolidated revenue of INR 4,224 crores and EBITDA of INR 198 crores.

    • Impairment loss of INR 898 crores recorded for the investment in CCVL due to structural reset in earnings outlook.

    • Exceptional charge of INR 150 crores for onerous contracts and raw material write-down in CCVL.

    • Persistent price pressures, excess global capacities, geopolitical disruptions, and PVC dumping impacted commodity business.

    • Regulatory support for PVC weakened, with QCOs rescinded and customs duty reduced (though temporary).

    Key financials

    Metrics

    9

    Periods

    4

    Headline

    1
    • Net Debt (as of March 31, 2026)
      ₹1,419 Cr

    Q4 FY26

    3
    • Consolidated Revenue
      ₹1,256 Cr
      YoY+9%
    • Consolidated EBITDA
      ₹194 Cr
    • Consolidated Net Loss
      ₹45 Cr

    FY26

    4
    • Consolidated Revenue
      ₹4,224 Cr
    • Consolidated EBITDA
      ₹198 Cr
    • Consolidated Net Loss
      ₹280 Cr
    • Impairment Provision
      ₹898 Cr

    CCVL FY26

    1
    • Exceptional Item
      ₹150 Cr

    Segment breakdown

    • Specialty Chemicals₹475 Cr37.8%
    • Value-added Chemicals₹120 Cr9.6%
    • Suspension PVC (CCVL)₹661 Cr52.6%
    Donut· Share of Revenue (Q4 FY26)

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Net ₹1,419 crores

    M&A

    Strategic Priorities & M&A Opportunities

    Other · announced

    Liquidity

    Liquidity disclosed

    Impairment loss does not affect liquidity or the company's ability to operate the business.

    Guidance & targets

    5
    CategoryTargetPriority
    Specialty Chemicals
    Paste PVC ADD implementation
    during first half of FY2026, '27
    Medium
    Custom Manufactured Chemicals
    Revenue target
    INR 1,000 crores
    Medium
    R32 Refrigerant Gas
    Capacity
    14 kt
    High
    Suspension PVC
    7.5% import duty
    come back into the system
    Medium
    Suspension PVC
    Regulatory support
    very critical from the medium to long-term point of view
    Medium

    Paste PVC ADD implementation

    H1 FY27
    CurrentFinal findings received, awaiting notification
    TargetImplementation of ADD

    Why it matters

    Crucial for improving realizations and margins in the Paste PVC business against imports.

    We await the notification by the Finance Minister. This has already resulted in relatively lower import bookings from Europe, while implementation of the ADD is now expected during first half of FY2026, '27.

    How to verify

    guidance_and_targets[category='Specialty Chemicals'][metric='Paste PVC ADD implementation']

    Risks & concerns

    6
    RiskSeverity

    Challenging FY26 & Commodity Market Volatility

    Persistent price pressures, excess global capacities, geopolitical disruptions, volatile feedstock/energy costs, and continued dumping of suspension PVC and paste PVC into India.Management acknowledged

    high

    Regulatory Uncertainty for PVC

    Delay in ADD implementation, rescinding of QCOs, and temporary reduction in customs duty for PVC imports, weakening regulatory support.Management acknowledged

    high

    Impairment Loss on CCVL Investment

    Non-cash impairment loss of INR 898 crores on CCVL investment due to a structural reset in the earnings outlook for the commodity business.Management acknowledged

    high

    Exceptional Charge for Onerous Contracts

    INR 150 crores charge for onerous contracts and raw material write-down in CCVL, though expected to be reversed in the current financial year.Management acknowledged

    high

    Agrochemical Market Slowdown

    Slowdown in global agrochemical market impacting Custom Manufactured Chemicals business, though believed to be temporary.Management acknowledged

    medium

    R32 Quota Allotment

    Uncertainty regarding government quota allotment for R32, which is critical for the large plant capacity. Management is confident based on overall country allocation.Analyst acknowledged

    medium

    Q&A highlights

    7

    “On a very, what you say, pessimistic end of the assumptions, yes, it is possible. But however, from what we also hear is the Chinese producers are also going through the stress. Second is end of June, we hope that the 7.5% duty comes back into the system. So that would add another what you say, $60, $70 to the pricing and the realization.”

    Analyst challenges management on the sustainability of the commodity business profitability given ongoing Chinese dumping and asks for FY27 outlook. Management acknowledges the pessimistic scenario but points to potential regulatory relief.

    asked by Sanjesh Jain

    2 min read5 chapters

    Detailed Narrative

    01

    Q4 & FY26 Performance Overview

    Chemplast Sanmar reported a challenging FY26 with consolidated revenue of INR 4,224 crores and EBITDA of INR 198 crores. Q4 FY26 saw a 9% YoY revenue growth to INR 1,256 crores and EBITDA of INR 194 crores, but a net loss of INR 45 crores. The year was significantly impacted by persistent price pressures, excess global capacities, and geopolitical disruptions, leading to an overall net loss of INR 280 crores for FY26.

    02

    Specialty Chemicals Segment Drives Growth

    The Specialty Chemicals segment was a bright spot, recording Q4 sales of INR 475 crores, a 13% YoY increase, with volumes growing 17% YoY. This segment contributed 38% to the total Q4 revenue. Paste PVC, a key product in this segment, saw stable demand from footwear and healthy traction from automotive and upholstery, with the Cuddalore facility operating at 100% capacity.

    03

    Challenges and Impairment in Commodity Business

    The Suspension PVC business, housed in CCVL, faced significant headwinds, with low-priced carbide PVC from China flooding the Indian market. This led to a sharp disconnect between PVC and feedstock VCM prices. Consequently, the company recorded a non-cash impairment loss of INR 898 crores on its investment in CCVL and an exceptional charge📎 of INR 150 crores for onerous contracts and raw material write-down for FY26.

    04

    Strategic Review and Regulatory Environment

    In response to the challenging environment, the Board constituted a committee of three independent directors to examine strategic priorities, including potential reorganization and M&A opportunities, to enhance long-term value. Management also highlighted weakening regulatory support for the PVC industry, with QCOs rescinded and temporary customs duty reductions, though they anticipate ADD implementation for Paste PVC in H1 FY27 and hope for the 7.5% duty to return for Suspension PVC by end of June 2026.

    05

    R32 Refrigerant Gas Commercialization and Custom Manufacturing Outlook

    The company commenced commercial production of R32 refrigerant gas at its 2 kt swing plant in Mettur, with plans to scale up to 14 kt capacity by the end of calendar year 2026, targeting both domestic and export markets. The Custom Manufactured Chemicals division, despite a slowdown in the global agrochemical market, shows early signs of recovery with a strong order book for FY27 and a pipeline of over 45 molecules, targeting INR 1,000 crores revenue for FY27.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.